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12:00PM–1:30PM Concurrent Session 1
Mechanisms of Nociception in OA
12:00PM – 12:30PM I-1. Mechanisms of Nociception in OA
Hans-Georg Schaible
p. S1
12:30PM – 12:40PM 1. A ROLE FOR CHEMOKINES AND NGF IN PAIN GENERATION IN A MURINE MODEL OF
OSTEOARTHRITIS
R.E. Miller, P. Tran, N. Ghoreishi-Haack, R. Das, A-M. Malfait; Rush Univ. Med. Ctr., Chicago, IL, USA
p. S7
12:40PM – 12:50PM 2. QUADRICEPS WEAKNESS PREDICTS WORSENING OF KNEE PAIN AND FUNCTION IN THE MOST
COHORT: A LONGITUDINAL STUDY
N. Segal1, N.A. Glass1, J. Torner1, K. Wang2, D.T. Felson2, M. Nevitt3, C.E. Lewis4; 1Univ. of Iowa, Iowa
City, IA, USA; 2Boston Univ., Boston, MA, USA ; 3Univ. of California at San Francisco, San Francisco, CA,
USA ; 4Univ. of Alabama at Birmingham, Birmingham, AL, USA
p. S7
12:50PM – 1:00PM 3. SERUM OPIOID MONITORING IN OSTEOARTHRITIS PATIENTS WITH CHRONIC PAIN: THE SEARCH
FOR SENSITIVE BIOMARKERS.
Y. Savitskaya, C. Duarte, N. Marin, R. Tellez, A. Alfaro, A. Izaguirre, E. Villalobos, A. Almazan, C. Ibarra;
Natl. Inst. of Rehabilitation, Mexico, Mexico
p. S8
1:00PM – 1:10PM 4. OSTEOPONTIN LEVEL IN SYNOVIAL FLUID IS ASSOCIATED WITH THE SEVERITY OF KNEE JOINT
PAIN
M. Yamaga, K. Tsuji, K. Miyatake, J. Yamada, I. Sekiya, T. Muneta; Tokyo Med. and Dental Univ., Tokyo,
Japan
p. S8
1:10PM – 1:20PM 5. IDENTIFYING PAIN VULNERABILITY PHENOTYPES IN OSTEOARTHRITIS
A.E. Nelson1, R.F. DeVellis1,2, B.M. DeVellis2, Y.M. Golightly1, W. Maixner3,4, J.M. Jordan1; 1Univ. of North
Carolina, Thurston Arthritis Res. Ctr., Chapel Hill, NC, USA; 2Univ. of North Carolina, Gillings Sch. of Global
Publ. Hlth., Dept. of Hlth.Behavior and Hlth.Ed., Chapel Hill, NC, USA ; 3Univ. of North Carolina, Sch. of
Med., Dept of Endodontics, Chapel Hill, NC, USA ; 4Univ. of North Carolina, Dept. of Pharmacy, Chapel Hill,
NC, USA
p. S8
1:20PM – 1:30PM 6. A NOVEL TECHNOLOGY TO DECREASE KNEE PAIN AND JOINT LOAD IN EARLY-ONSET KNEE
OSTEOARTHRITIS
J. Takacs1, J.R. Leiter2,3, J.D. Peeler1,3; 1Dept. of Human Anatomy and Cell Sci., Univ. of Manitoba,
Winnipeg, MB, Canada; 2Dept. of Human Anatomy and Cell Sci., Dept. of Surgery, Univ. of Manitoba,
Winnipeg, MB, Canada ; 3Pan Am Clinic, Winnipeg, MB, Canada
p. S9
12:00PM–1:30PM Concurrent Session 2
Frontiers in Imaging OA Joints
12:00PM – 12:30PM I-2. Frontiers in Imaging OA Joints
Marie Antonietta D’Agostino, MD
p. S1
12:30PM – 12:40PM 7. PROGNOSIS OF CARTILAGE LOSS BY ANALYZING MAGNETIC RESONANCE IMAGING OF THE TIBIA
TRABECULAR BONE STRUCTURE
J. Marques1,2, E. Dam2; 1Univ. of Copenhagen, Copenhagen, Denmark; 2BiomedIQ S/A, Rødovre, Denmark
p. S9
12:40PM – 12:50PM 8. BONE MARROW LESIONS IN KNEE OSTEOARTHRITIS CHANGE IN 6 TO 12 WEEKS
D.T. Felson1, M.J. Callaghan1, M. Parkes1, E.J. Marjanovic1, M. Lunt1, J.A. Oldham1, A. Gait1,
C.E. Hutchinson2; 1Univ. of Manchester, Manchester, United Kingdom; 2Univ. of Warwick, Warwick, United
Kingdom
p. S10
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12:50PM – 1:00PM 9. RELATIONSHIP BETWEEN ARTHROSCOPIC FINDINGS AT THE TIME OF ACL RECONSTRUCTION AND
TIBIOFEMORAL JOINT SPACE WIDTH.
T.W. Tourville, R.J. Johnson, S. Naud, J.R. Slauterbeck, B.D. Beynnon; Univ. of Vermont, Burlington, VT,
USA
p. S11
1:00PM – 1:10PM 10. IN VIVO MRI UTE-T2* IS ELEVATED IN BOTH TORN AND SURFACE INTACT HUMAN MENISCI OF
ANTERIOR CRUCIATE LIGAMENT INJURED KNEES
A. Williams, Y. Qian, C.R. Chu, M. Bowers; Univ. of Pittsburgh, Pittsburgh, PA, USA
p. S11
1:10PM – 1:20PM 11. THE PATELLOFEMORAL JOINT IS THE MOST COMMON COMPARTMENT AFFECTED BY STRUCTURAL
FEATURES OF KNEE OSTEOARTHRITIS USING MAGNETIC RESONANCE IMAGING DATA
J. Stefanik1, J. Niu1, K.D. Gross1,2, F. Roemer3, A. Guermazi1, D. Felson1; 1BUSM, Boston, MA, USA;
2MGHIHP, Boston, MA, USA ; 3Klinikum Augsburg, Augsburg, Germany
p. S12
1:20PM – 1:30PM 12. IDENTIFICATION OF MRI MORPHOLOGIC FEATURES ASSOCIATED WITH DIFFERENT KNEE PAIN
PATTERNS
C.K. Kwoh1, R. Boudreau2, A. Guermazi3, M.J. Hannon2, S.M. Green2, J.M. Jakicic4, C. Moore5,
F.W. Roemer6; 1Univ. of Pittsburgh/VA Pittsburgh Hlth.care System, Pittsburgh, PA, USA; 2Univ. of
Pittsburgh Sch. of Med., Pittsburgh, PA, USA ; 3Quantitative Imaging Ctr., Boston Univ. Sch. of Med., Boston,
MA, USA ; 4Univ. of Pittsburgh Sch. of Ed., Pittsburgh, PA, USA ; 5Texas Woman’s Univ., Houston, TX, USA ;
6Klinikum Augsburg, Augsburg, Germany
p. S12
2:00PM–3:30PM Plenary Session 1
Metabolism, Inﬂammation & OA
2:00PM – 2:30PM Metabolism, Inﬂammation & OA
Clay Semenkovich, MD
2:30PM – 2:40PM 13. OSTEOARTHRITIS SEVERITY IS ASSOCIATED WITH INCREASED RISK FOR DIABETES AND HEART
DISEASE
G.A. Hawker, A. Warner, T. Simms; Women’s Coll. Hosp., Toronto, ON, Canada
p. S13
2:40PM – 2:50PM 14. SERUM ADIPOKINES IN END-STAGE OSTEOARTHRITIS; COMPARISON WITH HEALTHY CONTROLS
AND RELATIONS WITH INTRA-ARTICULAR JOINT CHARACTERISTICS
T.N. de Boer1, S.C. Mastbergen1, A.M. Huisman2, J.W. Bijlsma1, F.P. Lafeber1; 1Rheumatology & Clinical
Immunology, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands; 2Rheumatology, Sint Franciscus Gasthuis,
Rotterdam, Netherlands
p. S13
2:50PM – 3: 00 PM 15. CARTILAGE IS NOT THE FIRST KNEE TISSUE TO DEGENERATE IN ASSOCIATION WITH FEMALE
HORMONAL ASPECTS
B.M. de Klerk, D. Schiphof, E.H. Oei, H. Weinans, A. Hofman, B. Koes, S.M. Bierma-Zeinstra; Erasmus
Univ. Med. Ctr., Rotterdam, Netherlands
p. S14
3:00PM – 3:10PM 16. ADIPOSE STROMAL CELLS DOWN-MODULATE INFLAMMATORY FACTORS IN SYNOVIOCYTES AND
CHONDROCYTES FROM OSTEOARTHRITIS PATIENTS
C. Manferdini1, A. Piacentini1, M. Maumus2, E. Gabusi1, J-A. Peyraﬁtte3, C. Jorgensen2, A. Facchini1,
D. Noel2, G. Lisignoli1; 1Istituto Ortopedico Rizzoli, IOR, Bologna, Italy; 2Inserm, Montpellier, France ;
3EFS-PM, Toulose, France
p. S14
3:10PM – 3:20PM 17. THE EFFECT OF BARIATRIC SURGERY ON THE RESOLUTION AND SEVERITY OF OSTEOARTHRITIS
AND OTHER OBESITY-RELATED COMORBIDITIES
J.X. Liu, J.K. Saunders, M. Parikh, S.B. Abramson; NYU Hosp. for Joint Diseases, New York, NY, USA
p. S14
3:20PM – 3:30PM 18. BODY COMPOSITION AND MENISCAL TEARS IN COMMUNITY BASED ADULTS
M. Davies-Tuck1, A. Wluka1, Y. Wang1, B. Strauss1, J. Martel-Pelletier2, J-P. Pelletier2, J. Proietto3,
J. Dixon4, S. Tanamas1, G. Jones5, F. Cicuttini1; 1Monash Univ., Melbourne, Australia; 2Univ. of Montreal
Hosp. Ctr., Montreal, QC, Canada ; 3Univ. of Melbourne, Melbourne, Australia ; 4Baker IDI Heart and
Diabetes Inst., Melbourne, Australia ; 5Menzies Res. Inst., Tasmania, Australia
p. S15
3:30PM–4:00PM BREAK
4:00PM–5:00PM Concurrent Session 3
Biomechanics (Cell & Tissue)
4:00PM – 4:30PM Biomechanics (Cell & Tissue)
Robert Sah, MD, ScD
4:30PM – 4:40PM 19. EFFECT OF MINERALIZATION ON THE MATERIAL PROPERTIES OF ARTICULAR CARTILAGE IN THE
RAT
M.L. Roemhildt, B. Beynnon, K. Anderson; Univ. of Vermont, Burlington, VT, USA
p. S15
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4:40PM – 4:50PM 20. ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE (AMPK) INHIBITS BIOMECHANICAL INJURY-
INDUCED CATABOLIC RESPONSES OF ARTICULAR CHONDROCYTES
F. Petursson1, M. Husa1, R. June1, D. D’Lima2,3, R. Terkeltaub1, R. Liu-Bryan1; 1VAMC Med.-Rheumatology,
UCSD, San Diego, CA, USA; 2Shiley Ctr. for Orthopaedic Res. and Ed., Scripps Clinic, La Jolla, CA, USA ; 3The
Scripps Res. Inst., La Jolla, CA, USA
p. S16
4:50PM – 5:00PM 21. LOAD-INDUCED PROGRESSIVE LESIONS ARE ASSOCIATED WITH PROTEOGLYCAN LOSS BUT NOT
WITH CELL DEATH.
B. Poulet1, I.M. Khan2, C.W. Archer2, A.A. Pistillides1; 1The Royal Vet. Coll., London, United Kingdom;
2Cardiff Sch. of BioSci.s, Cardiff, United Kingdom
p. S16
4:00PM–5:00PM Concurrent Session 4
Biomechanics (Clinical Perspectives)
4:00PM – 4:30PM I-3. Biomechanics (Clinical Perspectives)
Tom Andriacchi, PhD
p. S1
4:30PM – 4:40PM 22. ABILITY OF PEAK KNEE ADDUCTION MOMENT AND KNEE ADDUCTION MOMENT IMPULSE TO
DISTINGUISH BETWEEN CLINICAL AND STRUCTURAL DISEASE SEVERITY
C.O. Kean, R.S. Hinman, K. Bowles, K.L. Bennell; Univ. of Melbourne, Melbourne, Australia
p. S16
4:40PM – 4:50PM 23. INCREASED DYNAMIC KNEE JOINT LOAD ON THE NON-OPERATIVE LIMB AFTER HIGH TIBIAL
OSTEOTOMY
A. Boulougouris1, T.B. Birmingham2, R.F. Moyer1, I.C. Jones1, J. Gifﬁn3; 1Wolf Orthopaedic Biomechanics
Labratory, London, ON, Canada; 2The Universtiy of Western Ontario, London, ON, Canada ; 3Fowler
Kennedy Sport Med. Clinic, London, ON, Canada
p. S17
4:50PM – 5:00PM 24. GAIT CHARACTERISTICS AND POTENTIAL EFFECT OF SUPERVISED EXERCISE THERAPY IN HIP
OSTEOARTHRITIS PATIENTS WITH MILD TO MODERATE PAIN. A RANDOMIZED CONTROLLED TRIAL.
I. Eitzen1, L. Fernandes1,2, K. Rydevik1, L. Nordsletten3, M. Risberg1; 1NAR/Oslo Univ. Hosp., Dept. of
Orthopaedics, The Norwegian Sch. of Sports Sci. and Hjelp24 NIMI, Oslo, Norway; 2Natl. Resource Ctr. for
Rehabilitation in Rheumatology, Dept. of Rheumatology, Diakonhjemmet Hosp., Oslo, Norway ; 3Oslo Univ.
Hosp., Dept. of Orthopaedics, Oslo, Norway
p. S17
5:00PM–5:30PM BREAK
5:30PM–6:15PM Presidential Address, Opening Ceremony / Lifetime Achievement Award
5:30PM – 6:00PM Presidential Address
Linda Sandell, PhD
6:00PM – 6:10PM Recognition of Young Investigators
6:10PM – 6:15PM Lifetime Achievement Award
Dick Heinegard, MD, PhD




7:00PM–8:30PM Opening Reception with Exhibitors
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7:30AM–9:00AM Satellite Breakfast Symposium
Symptom Control in Osteoarthritis: Evidence with SYSADOAs, Sponsored by Bioiberica
7:30AM – 8:30AM I-5. Breakfast Workshop A – Cell Therapy Options
A. Hari Reddi, PhD
p. S2
7:30AM – 8:30AM Breakfast Workshop B – Setting Up Clinical Trials
Timothy McAlindon, MD, MPH
9:00AM–10:00AM Plenary Session 2
Basic and Clinical Award Presentations and OARSI Business Meeting
10:00AM–10:30AM BREAK
10:30AM–12:00PM Concurrent Session 5
Inﬂammation & Immunity in OA
10:30AM – 11:00AM I-6. Inﬂammation & Immunity in OA
Ru Liu-Bryan, PhD
p. S2
11:00AM – 11:10AM 25. ELUSIVE ROLE FOR TOLL LIKE RECEPTOR 2 IN JOINT PATHOLOGY DURING EXPERIMENTAL
OSTEOARTHRITIS.
A.B. Blom, P.L. van Lent, S. Abdollahi-Roodsaz, P. van der Kraan, W. van den Berg; Radboud Univ.
Nijmegen Med. Ctr., Nijmegen, Netherlands
p. S18
11:10AM – 11:20AM 26. SYNOVIAL FLUID FROM PATIENTS WITH OSTEOARTHRITIS AND MENISCAL INJURY MODULATES
THE RESPONSE OF FIBROBLAST-LIKE SYNOVIOCYTES TO TLR-2 AND TLR-4 LIGANDS VIA SOLUBLE
CD14
C.R. Scanzello1, A. Nair1, V. Kanda1, C. Bush-Joseph1, N. Verma1, S. Chubinskaya1, K. Mikecz1,
A-M. Malfait1, M.K. Crow2, G.T. Spear1, A. Finnegan1; 1Rush Univ. Med. Ctr., Chicago, IL, USA; 2Hosp. for
Special Surgery, New York, NY, USA
p. S18
11:20AM – 11:30AM 27. SOLUBLE PROTEINS DERIVED FROM INFRAPATELLAR FAT PAD ADIPOCYTES OF OSTEOARTHRITIS
PATIENTS MODULATE CD4+ T CELL CYTOKINE PRODUCTION
A. Ioan-Facsinay, J.C. Kwekkeboom, M. Kloppenburg, R.E. Toes; Leiden Univ. Med. Ctr., Leiden,
Netherlands
p. S18
11:30AM – 11:40AM 28. TENASCIN-C LEVELS IN SYNOVIAL FLUID ARE ELEVATED AFTER HUMAN JOINT INJURY AND
CORRELATE WITH MARKERS OF MATRIX DEGRADATION AND INFLAMMATION
P.S. Chockalingam1, W. Sun1, S. Lohmander2,3; 1Inﬂammation & Remodelling, Pﬁzer, Cambridge, MA,
USA; 2Lund Univ., Lund, Sweden ; 3Univ. of Southern Denmark, Odense, Denmark
p. S19
11:40AM – 11:50AM 29. “ALARMINS” S100A8 AND A9 ARE EXPRESSED IN THE SYNOVIUM OF EARLY OA PATIENTS AND
ARE INVOLVED IN DRIVING SYNOVIAL ACTIVATION AND JOINT DESTRUCTION DURING EXPERIMENTAL
OSTEOARTHRITIS.
P. van Lent; Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
p. S19
11:50AM – 12:00PM 30. ONCOSTATIN M POTENTLY INDUCES IL-6 AND RANKL EXPRESSION IN MOUSE SYNOVIAL
FIBROBLASTS AND SIGNIFICANTLY ENHANCES THE EFFECTS OF IL-1 AND TNF
B. Le Goff1, B.A. Tonkin1, S. Singbrant1, T.J. Martin1,2, E. Romas1,2, N.A. Sims1,2, N.C. Walsh1,2; 1St Vincent’s
Inst. of Med. Res., Melbourne, Australia; 2Dept. of Med., St Vincent’s Hosp., Univ. of Melbourne, Melbourne,
Australia
p. S20
10:30AM–12:00PM Concurrent Session 6
Societal, Psychological & Economic Impact of OA
10:30AM – 11:00AM I-7. Qualitative Research for Osteoarthritis: Better Understand Patients and Care Providers Views and
Needs to Improve Management Strategies
Serge Poiraudeau, MD, PhD
p. S2
11:00AM – 11:10AM 31. SMART, THIN WOMEN WITH HIGHER VITAMIN D INTAKE AND TALL MEN WITH A HAPPY
CHILDHOOD ARE PROTECTED FROM ULTRASOUND FEATURES OF HIP OSTEOARTHRITIS: THE
NEWCASTLE THOUSAND FAMILIES STUDY
A. Abraham1, M.S. Pearce1, K.D. Mann1, R.M. Francis2, F. Birrell3; 1Inst. of Hlth.and Society, Newcastle
Univ., Newcastle upon Tyne, United Kingdom; 2Inst. for Ageing and Hlth., Newcastle Univ., Newcastle upon
Tyne, United Kingdom ; 3Musculoskeletal Res. Group, Inst. of Cellular Med., Newcastle Univ., Newcastle
upon Tyne, United Kingdom
p. S20
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11:10AM – 11:20AM 32. ESTIMATING THE LIFETIME RISK OF TOTAL HIP AND KNEE REPLACEMENT IN THE UNITED
KINGDOM
D. Culliford1, A. Kiran2, A. Judge2, N.K. Arden2; 1Univ. of Southampton, Southampton, United Kingdom;
2Univ. of Oxford, Oxford, United Kingdom
p. S21
11:20AM – 11:30AM 33. IDENTIFYING PREDICTORS OF PATIENT REPORTED OUTCOMES OF PRIMARY HIP REPLACEMENT
SURGERY: A MULTI-CENTRE POPULATION BASED COHORT STUDY
A. Judge1, R. Batra1, D. Beard1, G. Thomas1, M. Javaid1,2, C. Cooper1,2, K. Barker3,1, J.G. Andrew4,
D. Murray1, N.K. Arden1,2; 1Oxford NIHR Musculoskeletal BioMed. Res. Unit, Nufﬁeld Dept. of Orthopaedics,
Rheumatology and Musculoskeletal Sci., Univ. of Oxford, Oxford, United Kingdom; 2MRC Epidemiology
Resource Ctr., Univ. of Southampton, Southampton, United Kingdom ; 3Physiotherapy Res. Unit, BRU, Univ.
of Oxford & Nufﬁeld Orthopaedic Ctr. NHS Trust, Oxford, United Kingdom ; 4Dept. of Orthopaedics, Ysbyty
Gwynedd District Hosp., Bangor, United Kingdom
p. S21
11:30AM – 11:40AM 34. OUTCOMES FOLLOWING TOTAL KNEE REPLACEMENT SURGERY FOR OA: THERE IS MORE THAN
JUST THE KNEE TO CONSIDER
A.V. Perruccio1, J.D. Power1, E.M. Badley1, R. Gandhi2, N.N. Mahomed2, A.M. Davis1; 1Toronto Western
Res. Inst.; Univ. of Toronto, Toronto, ON, Canada; 2Toronto Western Hosp.; Univ. of Toronto, Toronto, ON,
Canada
p. S22
11:40AM – 11:50AM 35. USE AND COSTS OF PHARMACOLOGIC AND ALTERNATIVE TREATMENTS IN PATIENTS WITH
OSTEOARTHRITIS IN COMMUNITY BASED SETTINGS IN THE UNITED STATES
M. Gore1, A. Sadosky2, D. Leslie3, K-S. Tai1, B.R. Stacey4; 1Avalon Hlth.Solutions, Inc, Philadelphia, PA,
USA; 2Pﬁzer, Inc., New York, NY, USA ; 3Penn State Coll. of Med., Hershey, PA, USA ; 4Oregon Hlth.and Sci.
Univ., Portland, OR, USA
p. S22
11:50AM – 12:00PM 36. A HIGH PREVALENCE AND IMPACT OF CHRONIC JOINT SYMPTOMS IN THE YOUNGER POPULATION:
IS THIS OSTEOARTHRITIS?
M. Canizares, E.M. Badley; Univ. Hlth.Networks, Toronto, ON, Canada
p. S22
12:00PM–1:30PM Satellite Lunch Symposium
I.A. Hyaluronic Acid: A Suitable Option to Improve Joint Mobility for Patient Well-Being, Sponsored by IBSA
1:30PM–3:00PM Concurrent Session 7
Micro-RNA & Posttranscriptional Gene Regulation
1:30PM – 2:00PM I-8. The Role of MIR-140 in OA Pathogenesis
Hiroshi Asahara, MD, PhD
p. S3
2:00PM – 2:10PM 37. THE mtDNA HAPLOGROUP J MODULATES THE NITRIC OXIDE (NO) PRODUCTION AND TELOMERE
LENGTH. ROLE IN OSTEOARTHRITIS (OA)
I. Rego-Pe´rez1, M. Tamayo2, A´. Soto-Hermida1, A. Mosquera2, M. Ferna´ndez-Moreno1, N. Oreiro1,
C. Ferna´ndez-Lo´pez1, J.L. Ferna´ndez2, M. Acasuso3, F.J. Blanco1; 1INIBIC-CHUAC. Rheumatology Div., A
Corun˜a, Spain; 2INIBIC-CHUAC. Genetics Unit, A Corun˜a, Spain ; 3Centro de Salud San Jose´ – SERGAS, A
Corun˜a, Spain
p. S23
2:10PM – 2:20PM 38. LOSS OF METHYLATION IN CPG SITES IN THE NUCLEAR FACTOR KAPPA B (NF-úB) ENHANCER
ELEMENTS OF INDUCIBLE NITRIC OXIDE SYNTHASE (INOS) IS RESPONSIBLE OF GENE INDUCTION IN
HUMAN ARTICULAR CHONDROCYTES
M.C. de Andre´s1,2, K. Imagawa1, K. Hashimoto3, M.B. Goldring3, A. Gonzalez2, J.J. Gomez-Reino2,
H.I. Roach1, R.O. Oreffo1; 1Univ. of Southampton. Sch. of Med., Southampton, United Kingdom; 2Hosp.
Clinico Univ.rio de Santiago, Santiago de Compostela, Spain ; 3Hosp. for Special Surgery, New York, NY,
USA
p. S23
2:20PM – 2:30PM 39. ESSENTIAL ROLE OF microRNA-146a IN THE PATHOGENESIS OF OSTEOARTHRITIS
X. Zhang, J. Li, K. Dai; The Key Lab. of Stem Cell Biology, Inst. of Hlth.Sci., Shanghai Jiao Tong Univ. Sch. of
Med. (SJTUSM) & Shanghai Inst.s for Biological Sci. (SIBS), Chinese Academy of Sci. (CAS), Shanghai, China
p. S24
2:30PM – 2:40PM 40. OVEREXPRESSION OF hsa-miR-148A PROMOTES TYPE II COLLAGEN SYNTHESIS BY
OSTEOARTHRITIC CHONDROCYTES
L.A. Vonk1, A.H. Kragten1, D.B. Saris1, W.J. Dhert1,2, L.B. Creemers1; 1UMC Utrecht, Utrecht, Netherlands;
2Univ. of Utrecht, Utrecht, Netherlands
p. S25
2:40PM – 2:50PM 41. CHANGES IN GENE EXPRESSION WITH AGE AND OSTEOARTHRITIS IN THE MOUSE KNEE JOINT
R. Loeser1, A. Olex1, M.A. McNulty2, C.S. Carlson3, M. Callahan1, C. Ferguson1, J.S. Fetrow1; 1Wake
Forest Univ., Winston Salem, NC, USA; 2Universtiy of Minnesota, St. Paul, MN, USA ; 3Univ. of Minnesota,
St. Paul, MN, USA
p. S25
2:50PM – 3:00PM 42. NFAT3 SPECIFICALLY REGULATES MIR-140 TRANSCRIPTION IN HUMAN OSTEOARTHRITIC
CHONDROCYTES
G. Tardif, D. Hum, H. Fahmi, J-P. Pelletier, J. Martel-Pelletier; Osteoarthritis Res. Unit, Univ. of Montreal
Hosp. Res. Ctr. (CRCHUM), Montreal, QC, Canada
p. S25
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1:30PM–3:00PM Concurrent Session 8
Hand OA: A Disease in Need of Treatment
1:30PM – 2:00PM I-9. Hand OA: A Disease in Need of Treatment
Krysia Dziedzec, PhD
p. S3
2:00PM – 2:10PM 43. EROSIVE THUMB BASE OSTEOARTHRITIS IN SYMPTOMATIC COMMUNITY-DWELLING ADULTS:
THE KEELE CLINICAL ASSESSMENT STUDIES
W-Y. Kwok1, M. Kloppenburg1, M. Marshall2, E. Nicholls2, F.R. Rosendaal3, D.A. van der Windt2,
G. Peat2; 1Leiden Univ. Med. Ctr., Dept. of Rheumatology, Leiden, Netherlands; 2Arthritis Res. UK
Primary Care Ctr., Keele, North Staffordshire, United Kingdom ; 3Leiden Univ. Med. Ctr., Dept. of Clinical
Epidemiology, Leiden, Netherlands
p. S26
2:10PM – 2:20PM 44. COMPARATIVE ANALYSIS OF BONE EROSIONS AND CYSTS IN RHEUMATOID ARTHRITIS, PSORIATIC
ARTHRITIS AND EROSIVE HAND OSTEOARTHRITIS
S. Finzel1, C. Ernet1, C. Stach1, K. Engelke2, M. Englbrecht1, G. Schett1; 1Univ. Clinic of Erlangen-
Nuremberg, Erlangen, Germany; 2Univ. of Erlangen-Nuremberg, Erlangen, Germany
p. S26
2:20PM – 2:30PM 45. MRI IN HAND OSTEOARTHRITIS: VALIDATION OF THE OSLO HAND OSTEOARTHRITIS MRI-SCORING
METHOD AND ASSOCIATION WITH PAIN
W-Y. Kwok1, M.C. Kortekaas1, M. Reijnierse2, D. van der Heijde1,3, J.L. Bloem2, M. Kloppenburg1;
1Leiden Univ. Med. Ctr., Dept. of Rheumatology, Leiden, Netherlands; 2Leiden Univ. Med. Ctr., Dept. of
Radiology, Leiden, Netherlands ; 3Diakonhjemmet Hosp., Dept. of Rheumatology, Oslo, Norway
p. S26
2:30PM – 2:40PM 46. THE ASSOCIATION BETWEEN EROSIVE HAND OSTEOARTHRITIS AND SUBCHONDRAL BONE
ATTRITION OF THE KNEE
I.K. Haugen1, D.T. Felson2, M. Englund3,2, K. Wang2, P. Aliabadi4, A. Guermazi2, F. Roemer2,5, T. Neogi2;
1Diakonhjemmet Hosp., Oslo, Norway; 2Boston Univ., Boston, MA, USA ; 3Lund Univ., Lund, Sweden ;
4Brigham amd Women’s Hosp., Boston, MA, USA ; 5Klinikum Augsburg, Augsburg, Germany
p. S27
2:40PM – 2:50PM 47. METRIC PROPERTIES OF IMAGING METHODS IN OSTEOARTHRITIS OF THE HAND: A SYSTEMATIC
REVIEW.
M.S. Saltzherr, R.W. Selles, S.M. Bierma-Zeinstra, G.S. Muradin, J.H. Coert, J.W. van Neck, J.J. Luime;
Erasmus MC, Rotterdam, Netherlands
p. S27
2:50PM – 3:00PM 48. WHAT TYPE OF ACTIVITY LIMITATIONS DO PATIENTS WITH HAND OSTEOARTHRITIS EXPERIENCE?
AN INTERVIEW STUDY OF 162 PATIENTS.
L. Fernandes1, M. Grotle1, S. Darre2, R. Nossum2, I. Kjeken1; 1Natl. Resource Ctr. for Rehabilitation in
Rheumatology, Diakonhjemmet Hosp., Oslo, Norway; 2St Olavs Hosp., Trondheim, Norway
p. S28
3:00PM–4:30PM Poster Session 1
4:30PM–6:00PM Plenary Session 3
Highest Rated Abstracts from Young Investigators
4:30PM – 4:40PM 49. EXOSOMES CONTAINING MICRORNAS FUNCTION IN A NOVEL COMMUNICATION PATHWAY
AMONG JOINT TISSUE CELLS
T. Takada1, T. Kato1, T. Nakasa1, H. Asahara2, M. Lotz2, M. Ochi1, S. Miyaki1; 1Hiroshima Univ., Hiroshima,
Japan; 2The Scripps Res. Inst., La Jolla, CA, USA
Young Investigator Award Winner
p. S28
4:40PM – 4:50PM 50. IN VITRO KNOCKDOWN OF SOX9 AFFECTS CELL SURVIVAL VIA P21 AND CYCLIN D1 AND FAVORS
OSTEOGENIC DIFFERENTIATION OF MSC
S. Stoeckl1,2, A. Bosserhoff3, C. Go¨ttl1,2, J. Grifka2, S. Gra¨ssel1,2; 1Ctr. for Med. Biotechnology, Regensburg,
Germany; 2Orthopaedic Surgery, Experimental Orthopaedics, Regensburg, Germany ; 3Dept. of Pathology,
Regensburg, Germany
Young Investigator Award Winner
p. S29
4:50PM – 5:00PM 51. FIBROBLAST GROWTH FACTORS 18 AND 9 REGULATE CHONDROGENIC DIFFERENTIATION OF
HUMAN MESENCHYMAL STEM CELLS
D. Correa1, E. Rom2, J.F. Welter1, L. Duesler1, A. Yayon2, A.I. Caplan1; 1Case Western Reserve Univ.,
Cleveland, OH, USA; 2ProCore Ltd., Ness Ziona, Israel
Young Investigator Award Winner
p. S29
5:00PM – 5:10PM 52. GSK-3a AND GSK-3b MODULATE EARLY STAGES OF CHONDROCYTE DIFFERENTIATION THROUGH
PHOSPHORYLATION OF RELA/NF-KAPPAB P65
S. Itoh, T. Saito, M. Hirata, M. Ushita, T. Ikeda, K. Nakamura, U-i. Chung, H. Kawaguchi; Sensory &
Motor System Med., Univ. of Tokyo, Tokyo, Japan
Young Investigator Award Winner
p. S29
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5:10PM – 5:20PM 53. THE TRANSCRIPTIONAL REGULATION OF MMP13 BY CPG METHYLATION IN HUMAN
CHONDROCYTES: HIF2-ALPHA IS A POTENTIAL TARGET
K. Hashimoto1, M. Otero1, K. Imagawa2, M.C. de Andre´s2, H.I. Roach2, R.O. Oreffo2, M.B. Goldring1;
1Hosp. for Special Surgery, New York, NY, USA; 2Univ. of Southampton, Southampton, United Kingdom
Young Investigator Award Winner
p. S30
5:20PM – 5:30PM 54. INTERACTION OF HUMAN MESENCHYMAL STROMAL CELLS AND REGULATORY T-CELLS IN
OSTEOARTHRITIS
S. Hagmann, B. Moradi, T. Mu¨ller, T. Dreher, S. Frank, W. Richter, T. Gotterbarm; Dept. of Orthopedics,
Trauma Surgery and Paraplegiology, Heidelberg Univ. Hosp., Heidelberg, Germany
Young Investigator Award Winner
p. S30
5:30PM – 5:40PM 55. MORE INFLAMMATORY SIGNS ON ULTRASOUND IN INTERPHALANGEAL JOINTS IN EROSIVE HAND
OSTEOARTHRITIS
M. Kortekaas, W-Y. Kwok, M. Reijnierse, T. Huizinga, M. Kloppenburg; Leiden Univ. Med. Ctr., Leiden,
Netherlands
Young Investigator Award Winner
p. S31
5:40PM – 5:50PM 56. THE ASSOCIATION OF PERIPHERAL AND CENTRAL SENSITIZATION WITH MUSCLE CO-ACTIVATION:
A COMMON MECHANISM AFFECTING PAIN AND FUNCTION IN KNEE OA?
T. Neogi1, J. Scholz2, J. Niu1, D. Felson1, N. Segal3, C. Woolf4, L. Arendt-Nielsen5, M. Nevitt6, L. Bradley7,
L. Frey-Law3; 1BUSM, Boston, MA, USA USA; 2Columbia, New York, NY USA ; 3Iowa, Iowa City, IA, USA ;
4Children’s Hosp., Boston, MA, USA ; 5Aalborg Univ., Aalborg, Denmark ; 6UCSF, San Francisco, CA, USA ;
7UAB, Birmingham, AL, USA
Young Investigator Award Winner
p. S31
5:50PM – 6:00PM 57. IDENTIFICATION AND DIFFERENT LOCALIZATION OF PROTEINS IN THE SUPERFICIAL AND THE
DEEP HUMAN OA CARTILAGE BY IMAGING MASS SPECTROMETRY
B. Cillero-Pastor1, G. Eijkel1, A. Kiss1, F. Blanco2, R. Heeren1; 1AMOLF-FOM Inst.. Netherlands Proteomics
Ctr., Amsterdam, Netherlands; 2Osteoarticular and Aging Res. Lab.. INIBIC-CHUAC, A Corun˜a, Spain
Young Investigator Award Winner
p. S32
6:30PM–7:30PM Meet the Professor Mentorship Session for OARSI Young Investigators
7:30PM–8:30PM Young Investigator Reception, Sponsored by EMD Serono, Inc.
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7:30AM–9:00AM Satellite Breakfast Symposium
Personalized Medicine: Tailoring Osteoarthritis Management to the Individual, Sponsored by Bioiberica
7:30AM – 8:30AM I-10. Breakfast Workshop C – Animal Models of OA Pain
Jeffrey Mogil, PhD
p. S3
7:30AM – 8:30AM Breakfast Workshop D – How to Assess Lower Limb Mechanics and Function
Doug Gross, MPT, ScD, FAAOMPT
9:00AM–10:30AM Concurrent Session 9
Cartilage Biology in OA
9:00AM – 9:30AM I-11. Cartilage Biology in Osteoarthritis: Activation of Matrix Degrading Enzymes
Christopher Little, PhD
p. S4
9:30AM – 9:40AM 58. HIGH ADAMTS4 OR 5 ACTIVITY AND SEVERE ARTICULAR CARTILAGE AGGRECAN DEPLETION
ONLY DO NOT LEAD TO OA IN YOUNG MICE UNDER STANDARD LABORATORY CONDITIONS
P.M. van der Kraan1, F. Kolb2, E.L. Vitters1, S. Barbieri2, U. Bodendorf2, N. Gerwin2, W.B. van den Berg1;
1Radboud Univ., Med. Ctr., Nijmegen, Netherlands; 2Novartis Inst.s for BioMed. Res., Basel, Switzerland
p. S32
9:40AM – 9:50AM 59. CARTILAGE-SPECIFIC DELETION OF PPAR-GAMMA IN MICE RESULTS IN EARLY ENDOCHONDRAL
OSSIFICATION DEFECTS AND ACCELERATED AGING-DEPENDENT DEVELOPMENT OF OSTEOARTHRITIS.
R. Monemdjou1, F. Vasheghani1, G. Perez1, M. Blati1, N. Taniguchi2, M. Lotz2, R. St-Arnaud3, H. Fahmi1,
J-P. Pelletier1, J. Martel-Pelletier1, F. Beier1, M. Kapoor1; 1Univ. of Montreal, Montreal, QC, Canada; 2The
Scripps Res. Inst., La Jolla, CA, USA ; 3Shriners Hosp. for Children, Montreal, QC, Canada
p. S33
9:50AM – 10:00AM 60. SIRT1-DEFICIENT MICE EXHIBIT AN ALTERED CARTILAGE PHENOTYPE AND UNDERGO INCREASED
CARTILAGE BREAKDOWN AND APOPTOSIS.
O.H. Gabay1, C. Sanchez2, M. Dvir-Ginzberg3, V. Gagarina1, E. Lee1, K.J. Zaal1, M.W. McBurney4,
D.J. Hall1; 1NIH, Bethesda, MD, USA; 2Bone and Cartilage Res. Unit, Inst. of Pathology B23, Univ. of Liege,
Liege, Belgium ; 3Lab. of Cartilage Biology, Inst. of Dental Sci., Faculty of Dental Med., Hebrew Univ. –
Hadassah Ein Kerem, Jerusalem, Israel ; 4Cancer Therapeutics, Ottawa Hosp. Res. Inst., 501 Smyth Road,
Box 926, Ottawa, ON, Canada
p. S33
10:00AM – 10:10AM 61. ELIMINATION OF MITOCHONDRIA RELATED BIM/BID PROTEINS REDUCES CHONDROCYTE
APOPTOSIS AFTER MECHANICAL INJURY
E. Eisner1, C.G. Davis2, J.J. Shelton1, R.S. Hotchkiss2, C.C. Chen1, J. Borrelli1; 1UT SouthWestern Med. Ctr.,
Dallas, TX, USA; 2Washington Univ., St. Louis, MO, USA
p. S33
10:10AM – 10:20AM 62. PERIOSTIN, AN OSTEOBLAST STIMULATING FACTOR, REGULATES CARTILAGE METABOLISM VIA
MMP-13 ACTIVATION
M. Attur1, G. Palmer1, Y. Tachida2, S. Kumakura2, K. Shimada2, S.B. Abramson1; 1NYUHosp. for Joint
Diseases, New York, NY, USA; 2Daiichi-Sankyo Co. Ltd., Tokyo, Japan
p. S34
10:20AM – 10:30AM 63. NATURAL HISTORY OF BONE AND CARTILAGE CHANGES IN OSTEOARTHRITIS IN GENETIC STRAINS
OF MICE
S. Hashimoto, M.F. Rai, J.M. Cheverud, L.J. Sandell; Washington Univ. Sch. of Med., St. Louis, MO, USA
p. S34
9:00AM–10:30AM Concurrent Session 10
OA Clinical Trials
9:00AM – 9:30AM OA Clinical Trials
Marc Hochberg, MD, MPH
9:30AM – 9:40AM 64. ORAL CALCITONIN DEMONSTRATED SYMPTOM-MODIFYING EFFICACY AND INCREASED
CARTILAGE VOLUME: RESULTS FROM A 2-YEAR PHASE 3 TRIAL IN PATIENTS WITH OSTEOARTHRITIS
OF THE KNEE
M.A. Karsdal1, P. Alexandersen2, M.R. John3, J. Loefﬂer3, M. Arnold3, M. Azria3, I. Byrjalsen1, B.J. Riis1,
C. Christiansen1; 1Nordic BioSci., Herlev, Denmark; 2Orla Lehmannsgade, Vejle, Denmark ; 3Novartis
Pharma, Basel, Switzerland
p. S35
9:40AM – 9:50AM 65. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF RHFGF18
ADMINISTERED INTRAARTICULARLY USING SINGLE OR MULTIPLE ASCENDING DOSES IN PATIENTS
WITH PRIMARY KNEE OSTEOARTHRITIS (OA), NOT EXPECTED TO REQUIRE KNEE SURGERY WITHIN 1
YEAR
R. McPherson1, K. Flechsenhar2, S. Hellot2, F. Eckstein3,4; 1PAREXEL Early Phase, Port Elizabeth, SOUTH
AFRICA; 2Merck Serono S.A. (an afﬁliate of Merck KGaA, Darmstadt, Germany), Geneva, Switzerland ;
3Paracelsus Med. Univ., Salzburg, Austria ; 4Chondrometrics GmbH, Ainring, Germany
p. S35
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9:50AM – 10:00AM 66. ROLE OF VITAMIN D IN OSTEOARTHRITIS KNEE: A SIX MONTH DOUBLE BLIND, RANDOMIZED,
PLACEBO CONTROL TRIAL
D. Sanghi1, R.N. Srivastava1, S. Agarwal2, S.M. Natu1, A. Singh1, S. Avasthi3; 1CSM Med. Univ., Lucknow,
India; 2SGPGIMS, Lucknow, India ; 3GSVM Med. Coll., kanpur, India
p. S36
10:00AM – 10:10AM 67. STRUCTURAL TISSUE CHANGES AND PROLONGED CLINICAL IMPROVEMENT BY JOINT DISTRACTION
IN TREATMENT OF END-STAGE KNEE OSTEOARTHRITIS; THE 2 YEARS FOLLOW-UP
K. Wiegant1, P.M. van Roermund2, F. Intema2, A.C. Marijnissen1, S. Cotofana3, F. Eckstein3,
S.C. Mastbergen1, F.P. Lafeber1; 1Rheumatology & Clinical Immunology, Univ. Med. Ctr. Utrecht, Utrecht,
Netherlands; 2Orthopaedics, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands ; 3Inst. of Anatomical and
Musculoskeletal research, Salzburg, Austria
p. S36
10:10AM – 10:20AM 68. EFFECTS OF VIDEO-BASED HOME EXERCISE ON CLINICAL AND RADIOGRAPHIC OUTCOMES IN
ADULTS WITH KNEE OSTEOARTHRITIS: A ONE-YEAR RANDOMIZED CONTROLLED TRIAL
H. Tohyama1, T. Chiba1, U. Kou2, H. Oka3, H. Kawaguchi4, K. Nakamura4, K. Ikoma1, K. Yasuda2;
1Hokkaido Univ. Hosp., Sapporo, Japan; 2Hokkaido Univ. Sch. of Med., Sapporo, Japan ; 322nd Century
Med. Ctr., The Univ. of Tokyo, Tokyo, Japan ; 4Sensory and Motor System Med., The Univ. of Tokyo, Tokyo,
Japan
p. S37
10:20AM – 10:30AM 69. PROSPECTIVE STUDY OF NEW KNEES FUNCTIONAL BRACE AND NEW TYPE INSOLE FOR MEDIAL
OSTEOARTHRITIS KNEE




Is Subchondral Bone or Articular Cartilage the Best Target for DMOAD Development?
11:00AM – 11:30AM I-12. Bone
David Findlay, PhD
p. S4
11:30AM – 12:00PM Cartilage
Alan Grodzinsky, ScD
12:00PM – 12:30PM Discussion
12:30PM–2:00PM Workshop for Young Investigators with the Editors of Osteoarthritis and Cartilage
2:00PM–3:30PM Concurrent Session 11
Chondrocyte Homeostasis
2:00PM – 2:30PM I-13. Chondrocyte Homeostasis
Richard Loeser, MD
p. S4
2:30PM – 2:40PM 70. RBPJK-DEPENDENT NOTCH SIGNALING IS REQUIRED FOR ARTICULAR CARTILAGE AND JOINT
MAINTENANCE
A.J. Mirando, T. Moore, A. Lang, A.M. Jesse, A. Kohn, M.J. Zuscik, R.J. O’Keefe, M.J. Hilton; Univ. of
Rochester Med. Ctr., Rochester, NY, USA
p. S37
2:40PM – 2:50PM 71. NOTCH/RBPJ/HES1 SIGNAL IN CHONDROCYTES MODULATES TERMINAL STAGE OF
ENDOCHONDRAL OSSIFICATION DURING SKELETAL GROWTH AND OSTEOARTHRITIS DEVELOPMENT
Y. Hosaka1, T. Saito1, S. Sugita1, A. Fukai1, T. Hikata2, H. Akiyama3, T. Nakamura3, K. Nakamura1,
U-I. Chung4, H. Kawaguchi1; 1Univ. of Tokyo, Graduate Sch. of Med., Tokyo, Japan; 2Keio Univ., Tokyo,
Japan ; 3Kyoto Univ., Kyoto, Japan ; 4Ctr. for Disease Biology and Integrative Med., Univ. of Tokyo, Tokyo,
Japan
p. S38
2:50PM – 3:00PM 72. ERG AND PTHRP GENETICALLY COOPERATE TO MAINTAIN ARTICULAR CARTILAGE LONG-TERM
FUNCTION
T. Okabe1, Y. Ohta2, S. Asai2, S. Wakitani3, M. Enomoto-Iwamoto2, M. Paciﬁci2, M. Iwamoto2; 1Natl.
Hosp. Organization, Shinshu Ueda Med. Ctr., Ueda, Nagano, Japan; 2Div. of Orthopedic Surgery, The
Children’s Hosp. of Philadelphia Res. Inst., Philadelphia, PA, USA ; 3Sch. of Hlth.and Sports Sci., Mukogawa
Women’s Univ., Nishinomiya, Hyogo, Japan
p. S38
3:00PM – 3:10PM 73. SYNOVIAL OVEREXPRESSION OF WNTS AND WISP1 LEADS TO OA-LIKE CARTILAGE DAMAGE AND
CHONDROCYTE PHENOTYPE CHANGE BY SKEWED TGF-b SIGNALING
M.H. van den Bosch, A.B. Blom, P.L. van Lent, H.M. van Beuningen, F.A. van de Loo, E.N. Blaney
Davidson, P.M. van der Kraan, W.B. van den Berg; Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands
p. S39
3:10PM – 3:20PM 74. ADAMTS-7 CONSTITUTES A POSITIVE FEEDBACK LOOP WITH TNFa IN REGULATING CARTILAGE
DEGRADATION AND OSTEOARTHRITIS
Y. Lai1, X. Bai1, Q. Tian1, Y. Chen2, B. Lee2, T. Appleton3, F. Beier3, C. Liu1; 1New York Univ., New York,
NY, USA; 2Baylor Coll. of Med., Houston, TX, USA ; 3Univ. of Western Ontario, London, ON, Canada
p. S39
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3:20PM – 3:30PM 75. GENERATION OF A TRANSGENIC KNOCK-IN MOUSE MODEL EXPRESSING ONLY THE IIA ISOFORM
OF TYPE II PROCOLLAGEN
S. Ravindran1, R. Lewis1, R.J. Fernandes2, A. McAlinden1; 1Washington Univ., St Louis, MO, USA; 2Univ.
of Washington, Seattle, WA, USA
p. S40
2:00PM–3:30PM Concurrent Session 12
Pain Physiology in OA
2:00PM – 2:30PM I-14. Pain Physiology in OA
Camilla Svensson, PhD
p. S4
2:30PM – 2:40PM 76. GREATER TROCHANTERIC PAIN IN HIP OSTEOARTHRITIS: INFLUENCE ON SYMPTOM SEVERITY
A. Brinks, R. Rozendaal, B.W. Koes, J.A. Verhaar, S.M. Bierma-Zeinstra; Erasmus MC, Univ. Med. Ctr.,
Rotterdam, Netherlands
p. S40
2:40PM – 2:50PM 77. ASSOCIATIONS BETWEEN INFLAMMATORY BIOMARKERS AND CHANGE IN KNEE PAIN OVER 5
YEARS IN OLDER ADULTS
C. Ding1,2, O. Stannus1, L. Blizzard1, G. Jones1; 1Univ. of Tasmania, Hobart, Australia; 2Monash Univ.,
Melbourne, Australia
p. S40
2:50PM – 3:00PM 78. THE COURSE OF PAIN IN HIP OSTEOARTHRITIS; DEFINING TRAJECTORIES OVER A TWO YEARS
TIME PERIOD
S.P. Verkleij1, T. Hoekstra2, P.A. Luijsterburg1, E. Waarsing1, B.W. Koes1, S.M. Bierma-Zeinstra1;
1Erasmus MC, Rotterdam, Netherlands; 2VU Univ., Amsterdam, Netherlands
p. S40
3:00PM – 3:10PM 79. THE ASSOCIATIONS BETWEEN LOW BACK PAIN, MORNING STIFFNESS AND LUMBAR DISC
DEGENERATION: A ROTTERDAM STUDY.
J. Scheele, E.I. de Schepper, P.A. Luijsterburg, A. Hofman, B.W. Koes, S.M. Bierma-Zeinstra; Erasmus
MC, Univ. Med. Ctr., Rotterdam, Netherlands
p. S41
3:10PM – 3:20PM 80. ASSOCIATION BETWEEN SEVERE PAIN IN THE EARLY MONTHS FOLLOWING TOTAL KNEE
REPLACEMENT AND FUNCTIONAL OUTCOMES OVER FIVE YEAR FOLLOW-UP
J.N. Katz1, E.A. Wright1, E.A. Lingard2, E. Losina1; 1Brigham and Women’s Hosp., Boston, MA, USA;
2Registrar in Publ. Hlth., Newcastle upon Tyne, United Kingdom
p. S41
3:20PM – 3:30PM 81. IMPACT OF EXERCISE TYPE AND DOSE ON PAIN IN KNEE OSTEOARTHRITIS: A SYSTEMATIC
REVIEW AND META-REGRESSION ANALYSIS
C. Juhl1,2, R. Christensen1,3, E.M. Roos1, W. Zhang4, H. Lund1; 1Res. Unit for Musculoskeletal Function and
Physiotherapy, Odense, Denmark; 2Dept. of Physiotherapy, Gentofte Hosp., Copenhagen, Denmark ; 3The
Parker Inst.: Musculoskeletal Statistics Unit, Copenhagen Univ. Hosp., Frederiksberg, Denmark ; 4Academic
Rheumatology, Univ. of Nottingham, Nottingham, United Kingdom
p. S42
3:30PM–5:00PM Poster Session 2
5:00PM–6:00PM Concurrent Session 13
Genetics & Epigenetics of OA
5:00PM – 5:30PM I-15. Genetics and the Functional Analysis of OA Susceptibility Loci
John Loughlin, PhD
p. S5
5:30PM – 5:40PM 82. THE ARCOGEN GENOME-WIDE ASSOCIATION STUDY
K. Panoutsopoulou; Wellcome Trust Sanger Inst., Hinxton, United Kingdom
p. S42
5:40PM – 5:50PM 83. ANALYSIS OF CANDIDATE OSTEOARTHRITIS GENES IN A META-ANALYSIS OF 8 GENOME-WIDE
ASSOCIATION STUDIES
C. Rodriguez-Fontela1, E. Evangelou2, A. Valdes3, M. Calaza1, The arcOGEN Consortium, N.K. Arden4,
S. Bos5, A. Cupples6, T. Esko7, J. Gomez-Reino1, H. Helgadottir8, A. Hofman9,10, I. Jonsdottir8,
H.J.M. Kerkhof9,10, I. Meulenbelt5,10, S. Metrustry3, A. Metspalu7, J. van Meurs9, E. Ntzani2,
K. Panoutsopoulou4, U. Styrkarsdottir8, U. Thorsteinsdottir8, G. Thorleifsson8, Y. Zhu6, D. Felson6,
J. Ioannidis2, K. Stefansson8, A. Uitterlinden9,10, E. Zeggini4, T. Spector3, A. Gonzalez1; 1Hosp. Clinico
Univ.rio de Santiago, Santiago de Compostela, Spain; 2Dept. of Hygiene and Epidemiology, University of
Ioannina School of Medicine, Ioannina, Greece ; 3Dept of Twin Res. and Genetic Epidemiology, St. Thomas’
Hospital, King’s College London, United Kingdom ; 4arcOGEN Consortium, Hinxton, United Kingdom
; 5Section of Molecular Epidemiology, Leiden University Medical Centre, Leiden, Netherlands ; 6Dept.
of Biostatistics, Boston University School of Public Health, Boston, MA, USA ; 7Estonian Genome Ctr.,
University of Tartu, Tartu, Estonia ; 8deCODE Genetics, Reykjavik, Iceland ; 9Dept. of Internal Med., Erasmus
Medical Center, Rotterdam, Netherlands ; 10The Netherlands Genomics Initiative-Sponsored Netherlands
Consortium for Hlth.y Aging, Rotterdam, Netherlands
p. S42
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5:50PM – 6:00PM 84. IDENTIFICATION OF INTERLEUKIN-16 AS A NOVEL EPIGENETICALLY-REGULATED FACTOR IN
CHONDROGENIC DIFFERENTIATION OF ADULT STEM CELLS
C. O’Flatharta1, E. Mooney1, G. Shaw1, B. Ranera2, G. McKenna1, M. Berdasco3, M. Esteller3, F. Barry1,
M. Murphy1; 1REMEDI, Natl. Univ. of Ireland Galway, Galway, Ireland; 2Univ. de Zaragoza, Zaragoza,
Spain ; 3L’Hosp.et de Llobregat, Barcelona, Spain
p. S43
5:00PM–6:00PM Concurrent Session 14
Rehabilitation & Non-Pharmacological Interventions
5:00PM – 5:30PM I-16. Adherence to Best Practice in the Conservative Management of Osteoarthriths
Nadine Foster, DPhil, BSc
p. S5
5:30PM – 5:40PM 85. NEUROMUSCULAR EXERCISE IMPROVES FUNCTIONAL PERFORMANCE IN PATIENTS WITH SEVERE
HIP OSTEOARTHRITIS
A. Villadsen1, E.M. Roos1, S. Overgaard2, A. Holsgaard-Larsen2; 1Res. unit for musculoskeletal function
and physiotherapy, Odense, Denmark; 2Orthopaedic Res. Unit, Dept. of Orthopaedics and Traumatology,
Odense Univ. Hosp., Inst. of Clinical Res., Univ. of Southern Denmark, Odense, Denmark
p. S44
5:40PM – 5:50PM 86. TIME TO TOTAL HIP REPLACEMENT SURGERY AFTER SUPERVISED EXERCISE AND PATIENT
EDUCATION IN PATIENTS WITH HIP OSTEOARTHRITIS. A RANDOMIZED INTERVENTION STUDY WITH
BETWEEN 3.5 AND 6 YEARS FOLLOW-UP.
I.C. Svege1, L. Fernandes2, L. Nordsletten3, M. Risberg4; 1NAR, Dept. of Orthopaedics, Oslo Univ. Hosp.
and Hjelp24NIMI, Oslo, Norway; 2NAR, Dept. of Orthopaedics, Oslo Univ. Hosp. and Hjelp24NIMI, and
Natl. Resource Ctr. for Rehabilitation in Rheumatology, Dept. of Rheumatology, Diakonhjemmet Hosp.,
Oslo, Norway, Oslo, Norway ; 3Dept. of Orthopaedics, Oslo Univ. Hosp. and and Faculty of Med., Univ. of
Oslo, Oslo, Norway ; 4NAR, Dept. of Sport medicine, Norwegian Sch. of Sport Sci., Hjelp24 NIMI, and Dept.
of Orthopaedics, Oslo Univ. Hosp., Oslo, Norway
p. S44
5:50PM – 6:00PM 87. WALKING LOADING AT THE KNEE PREDICTS MRI-DERIVED CARTILAGE THICKNESS CHANGES IN
MEDIAL COMPARTMENT KNEE OSTEOARTHRITIS
J. Erhart1,2, J. Favre2, T. Andriacchi2,1; 1Palo Alto VA, Palo Alto, CA, USA; 2Stanford Univ., Stanford, CA, USA
p. S45
7:30PM–10:30PM Congress Dinner
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9:00AM–10:30AM Concurrent Session 15
Stem Cell Therapies in OA
9:00AM – 9:30AM I-17. Stem Cell Therapies in OA
Farshid Guilak, PhD
p. S5
9:30AM – 9:40AM 88. GENOME WIDE EXPRESSION PROFILING OF NORMAL, RHEUMATOID AND OSTEOARTHRITIC
SYNOVIAL STEM CELLS
R.J. Krawetz, P.S. Lee, D.A. Hart, C.B. Frank; Univ. of Calgary, Calgary, AB, Canada
p. S45
9:40AM – 9:50AM 89. NORMAL AND OSTEOARTHRITIC SYNOVIAL STEM CELL-DERIVED TISSUE-ENGINEERED
CONSTRUCTS RESPOND TO MECHANICAL STIMULUS FOLLOWING CHONDROGENIC DIFFERENTIATION
G. Buckley-Herd1, R. Krawetz2, D.A. Hart2; 1BioMed. Engineering, Univ. of Calgary, Calgary, AB, Canada;
2Dept. of Surgery, Univ. of Calgary, Calgary, AB, Canada
p. S46
9:50AM – 10:00AM 90. A QUANTITATIVE PROTEOMICS APPROACH FOR STUDYING THE CHONDROGENIC DIFFERENTIATION
PROCESS OF MESENCHYMAL STEM CELLS
B. Rocha, P. Ferna´ndez-Puente, J. Mateos, V. Calamia, L. Lourido, C. Ferna´ndez-Costa, C. Ruiz-Romero,
F.J. Blanco; Osteoarticular and Aging Res. Lab., Proteomics Unit-Associated Node to ProteoRed-ISCIII,
INIBIC-CHUAC, A Corun˜a, Spain
p. S46
10:00AM – 10:10AM 91. MESENCHYMAL STEM CELLS EXERT PARACRINE EFFECTS ON OSTEOARTHRITIC CARTILAGE AND
SYNOVIUM.
G.M. van Buul, E. Villafuertes, J.H. Waarsing, P.K. Bos, N. Kops, J.A. Verhaar, H. Weinans, M.R. Bernsen,
G.J. van Osch; Erasmus MC, Rotterdam, Netherlands
p. S47
10:10AM – 10:20AM 92. DIRECT HUMAN CARTILAGE REPAIR USING THERMAL INKJET PRINTING TECHNOLOGY
X. Cui1, K. Breitenkamp1, M. Finn1, M. Lotz1, C. Colwell2, D. D’Lima1,2; 1The Scripps Res. Inst., La Jolla,
CA, USA; 2Shiley Ctr. for Orthopaedic Res. and Ed. (SCORE) at Scripps Clinic, La Jolla, CA, USA
p. S47
10:20AM – 10:30AM 93. IDENTIFICATION OF CHONDROGENIC PROGENITOR CELLS IN INJURED BOVINE ARTICULAR
CARTILAGE.
Y. Yu, D. Seol, D. McCabe, H. Zheng, J. Martin; Univ. of Iowa, Iowas City, IA, USA
p. S48
9:00AM–10:30AM Concurrent Session 16
Hip Shape & OA: Prevention & Management
9:00AM – 9:30AM I-18. Hip Shape & OA: Prevention & Management
Young Jo Kim, MD, PhD
p. S5
9:30AM – 9:40AM 94. RELATIONSHIP BETWEEN HIP ADDUCTION MOMENT, HIP ABDUCTOR STRENGTH AND
PROGRESSION OF KNEE OSTEOARTHRITIS
C.O. Kean, K.L. Bennell, K. Bowles, R.S. Hinman; Univ. of Melbourne, Melbourne, Australia
p. S49
9:40AM – 9:50AM 95. KNEE ALIGNMENT MAY INFLUENCE PERI-ARTICULAR BONE MORPHOLOGY
G.H. Lo1,2, T.E. McAlindon3; 1Michael E. DeBakey Dept. of Veteran’s Affairs Med. Ctr., Houston, TX, USA;
2Baylor Coll. of Med., Houston, TX, USA ; 3Tufts Med. Ctr., Boston, MA, USA
p. S49
9:50AM – 10:00AM 96. RISK FACTORS FOR REVISION OF PRIMARY TOTAL HIP REPLACEMENT: A NATIONAL CASE CONTROL
STUDY WITH TWELVE YEAR FOLLOW-UP
J.N. Katz1, E.A. Wright1, J.A. Baron2, H. Malchau3, N.N. Mahomed4, E. Losina1; 1Brigham and Women’s
Hosp., Boston, MA, USA; 2Univ. of North Carolina, Chapel Hill, NC, USA ; 3Massachusetts Gen. Hosp.,
Boston, MA, USA ; 4Toronto Western Hosp., Toronto, ON, Canada
p. S50
10:00AM – 10:10AM 97. SAGITTAL PLANE HIP MOTION DURING GAIT AND FUNCTION AND DISABILITY IN KNEE
OSTEOARTHRITIS
K. Moisio, C. Colbert, O. Almagor, J. Chmiel, A. Chang, J. Zhang, S. Cahue, K. Hayes, C. Saurel, L. Sharma;
Northwestern Univ., Chicago, IL, USA
p. S50
10:10AM – 10:20AM 98. DIAGNOSIS OF EARLY OSTEOARTHRITIS BY KNEE JOINT CONGRUITY QUANTIFIED AUTOMATICALLY
FROM MRI
S. Tummala1, E.B. Dam2, M. Nielsen1,2; 1University of Copenhagen, Copenhagen, Denmark; 2BiomedIQ
A/S, Rødovre, Denmark
p. S51
10:20AM – 10:30AM 99. MRI-BASED 3D BONE SHAPE PREDICTS INCIDENT KNEE OA 12-MONTHS PRIOR TO ITS ONSET
T. Neogi1, M. Bowes2, J. Niu1, K. De Souza2, J. Goggins1, Y. Zhang1, D. Felson1; 1BUSM, Boston, MA, USA;
2Imorphics Ltd., Manchester, United Kingdom
p. S51
10:30AM–10:45AM BREAK, Sapphire West Foyer
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10:45AM–12:15PM Plenary Session 4
OA Year in Review
I-19. Rehabilitation & Outcomes





Timothy McAlindon, MD, MPH
Genetics
Ingrid Meulenbelt, PhD
I-20. Biomarkers
Yves Henrotin, PhD
p. S6
I-21. Imaging
Ali Guermazi, MD
p. S6
